| Financial Year |
March 31 2023 |
| Monetary Funds |
436,825,145.98 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
94,007,589.24 |
| Accounts Receivable |
841,016,708.76 |
| Advances to Suppliers |
42,531,481.17 |
| Other Receivables |
5,269,185.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
542,194,870.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
44,221,140.13 |
| Other Current Assets |
25,433,827.97 |
| Total Current Assets |
2,070,259,692.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
42,166,173.22 |
| Long-term Equity Investment |
10,440,249.25 |
| Investment Properties |
2,734,820.76 |
| Fixed Assetes |
527,414,945.92 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
97,266,759.29 |
| R&D expenses |
-- |
| Goodwill |
366,088,626.69 |
| Long-Term Deferred and Prepaid Expenses |
14,832,008.98 |
| Deferred Income Tax Assets |
116,476,490.75 |
| Other Non-Current Assets |
32,034,576.38 |
| Sub-Total of Non-Current Assets |
1,211,520,275.59 |
| Total Assets |
3,281,779,968.58 |
| Short-Term Loans |
181,104,958.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
82,176,300.51 |
| Accounts Payable |
157,747,634.29 |
| Accounts Received In Advance |
941,896.02 |
| Employee Compensation Payable |
12,258,740.62 |
| Taxes Payable |
3,625,836.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,538,921.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
38,481,046.54 |
| Other Current Liabilities |
92,175,689.53 |
| Sub-Total of Current Liabilities |
858,888,179.04 |
| Long-term Loans |
35,660,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
63,978,120.89 |
| Special Payable |
-- |
| Estimatied Liabilities |
7,861,857.67 |
| Deferred Income Tax Liabilities |
4,265,223.17 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
157,561,287.68 |
| Total Liabilities |
1,016,449,466.72 |
| Paid-In Capital(Or Share Stock) |
1,007,690,641.00 |
| Capital Surplus |
3,024,039,763.82 |
| Surplus Reserve |
32,940,729.95 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,837,101,139.68 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,265,330,501.86 |
| Owner's Equity（Stockholder's Equity） |
2,265,330,501.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,281,779,968.58 |
